These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37312652)

  • 1. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
    Wang W; Kaelber DC; Xu R; Berger NA
    JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
    Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC
    JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
    Ge J; Digitale JC; Pletcher MJ; Lai JC;
    Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.
    Kshirsagar M; Nasir M; Mukherjee S; Becker N; Dodhia R; Weeks WB; Ferres JL; Richardson B
    JMIR Public Health Surveill; 2022 Nov; 8(11):e38898. PubMed ID: 36265135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
    Lombardi A; Villa S; Colaneri M; Scaglione G; Bai F; Varisco B; Bono V; Vena A; Dentone C; Russo C; Tettamanti M; Renisi G; Viero G; Azzarà C; Mantero M; Peyvandi F; Bassetti M; Marchetti G; Muscatello A; Nobili A; Gori A; Bandera A;
    J Infect Public Health; 2024 Mar; 17(3):467-473. PubMed ID: 38262085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.
    Butt AA; Nafady-Hego H; Chemaitelly H; Abou-Samra AB; Khal AA; Coyle PV; Kanaani ZA; Kaleeckal AH; Latif AN; Masalmani YA; Bertollini R; Raddad LJA
    Int J Infect Dis; 2021 Sep; 110():353-358. PubMed ID: 34375762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes.
    Marfella R; Sardu C; D'Onofrio N; Prattichizzo F; Scisciola L; Messina V; La Grotta R; Balestrieri ML; Maggi P; Napoli C; Ceriello A; Paolisso G
    Nat Commun; 2022 Apr; 13(1):2318. PubMed ID: 35484164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
    van Diepen S; McAlister FA; Chu LM; Youngson E; Kaul P; Kadri SS
    Crit Care Med; 2023 Sep; 51(9):1201-1209. PubMed ID: 37192450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
    Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the Cologne Corona Surveillance (CoCoS) project- a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection, and moderate-to-severe course in primarily immunized adults.
    Oberste M; Asenova T; Ernst A; Shah-Hosseini K; Schnörch N; Buess M; Rosenberger KD; Kossow A; Dewald F; Neuhann F; Hellmich M
    BMC Public Health; 2024 Feb; 24(1):548. PubMed ID: 38383381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.
    Wu JT; La J; Branch-Elliman W; Huhmann LB; Han SS; Parmigiani G; Tuck DP; Brophy MT; Do NV; Lin AY; Munshi NC; Fillmore NR
    JAMA Oncol; 2022 Feb; 8(2):281-286. PubMed ID: 34854921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.
    Whittaker R; Bråthen Kristofferson A; Valcarcel Salamanca B; Seppälä E; Golestani K; Kvåle R; Watle SV; Buanes EA
    Clin Microbiol Infect; 2022 Jun; 28(6):871-878. PubMed ID: 35219807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago.
    Moreno Echevarria F; Caputo M; Camp D; Reddy S; Achenbach CJ
    PLoS One; 2024; 19(8):e0302338. PubMed ID: 39102410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study.
    Bahl A; Johnson S; Maine G; Garcia MH; Nimmagadda S; Qu L; Chen NW
    Lancet Reg Health Am; 2021 Dec; 4():100065. PubMed ID: 34522911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.